TABLE 2.
Demographic Characteristics With and Without Stabilized IPTW
| Characteristic | Without Stabilized IPTW | With Stabilized IPTW | ||
|---|---|---|---|---|
| Larotrectinib (n = 82) | RW Control (n = 82) | Larotrectinib (n = 82) | RW Control (n = 82) | |
| Age, years | ||||
| Mean | 52.7 | 58.7 | 56.3 | 56.9 |
| Standard deviation | 17.2 | 12.2 | 16.8 | 12.1 |
| Race, % | ||||
| White | 61 | 74 | 66 | 67 |
| Other/Unknown | 39 | 26 | 34 | 33 |
| Sex, % | ||||
| Male | 48 | 46 | 48 | 48 |
| Female | 52 | 54 | 52 | 52 |
| Presence of metastases at index date, % | ||||
| Yes | 93 | 79 | 87 | 86 |
| No | 7 | 21 | 13 | 14 |
| ECOG PS at index, % | ||||
| 0-1 | 87 | 77 | 85 | 83 |
| 2-3 | 13 | 23 | 15 | 17 |
Abbreviations: ECOG PS, Eastern Cooperative Oncology Group performance status; IPTW, inverse probability of treatment weighting; RW, real-world.